Abstract: The present disclosure provides a pump body assembly, a heat exchange apparatus, a fluid machine and an operating method thereof. The pump body assembly includes a piston, a shaft, a piston sheath, and a cylinder. The shaft drives the piston to rotate and reciprocate within the piston sheath while rotating. The piston sheath is located in the cylinder, and a compression chamber is defined between an outer circumferential wall of the piston and an inner wall of the cylinder. A pressure relief recess is defined in the outer circumferential wall of the piston or the inner wall of the cylinder at a position corresponding to the compression chamber.

Abstract: The present disclosure provides a pump body, a compressor, and a heat exchange apparatus. The pump body includes a cylinder assembly, a piston, a motion transmission structure, and a drive member. The cylinder assembly includes a cylinder. The piston is movably disposed in the cylinder. The drive member is connected to the piston through the motion transmission structure. An outer peripheral wall of the piston has a rail groove connected end to end in a circumferential direction, and the cylinder has a guide structure extending into the rail groove; or an inner surface of the cylinder has a rail groove connected end to end in the circumferential direction, and the piston has a guide structure extending into the rail groove. So that through driving of the piston by the drive member, the piston is capable of rotating relative to the cylinder while reciprocating along a rotating axis of the piston.

Abstract: The present disclosure provides a pump body assembly, a heat exchange apparatus, a fluid machine and an operating method thereof. The pump body assembly includes a piston, a shaft, a piston sheath, and a cylinder. The shaft drives the piston to rotate and reciprocate within the piston sheath while rotating. The piston sheath is located in the cylinder, and a compression chamber is defined between an outer circumferential wall of the piston and an inner wall of the cylinder. A pressure relief recess is defined in the outer circumferential wall of the piston or the inner wall of the cylinder at a position corresponding to the compression chamber.

Abstract: Provides are a display substrate and a manufacturing method thereof, a display device. The display substrate includes a base substrate; a micro LED backlight array, including a first sub-array of micro LEDs and a second sub-array of micro LEDs; a color conversion layer on the micro LED backlight array, the color conversion layer including: a first color conversion unit array, an orthogonal projection of which on the base substrate overlaps with that of the first sub-array of micro LEDs on the base substrate and does not overlap with that of the second sub-array of micro LEDs on the base substrate; a second color conversion unit array, an orthogonal projection of which on the base substrate overlaps with that of the second sub-array of the micro LEDs on the base substrate and does not overlap with that of the first sub-array of micro LEDs on the base substrate.

Abstract: Method and media for diagnosing Crohn's disease are provided. A method of diagnosing Crohn's disease in patients includes: obtaining a sample from an individual; culturing the sample to determine the presence or absence of Mycobacterium avium subspecies hominissuis (MAH) in the sample; and diagnosing the individual with Crohn's disease based on the determining the presence of MAH in the sample.

Abstract: This disclosure relates to a method for direct reprogramming (transdifferentiation) of human fibroblasts into hepatocytes by small molecules. A method and a small molecule composition for direct reprogramming (transdifferentiation) of human fibroblasts into hepatocytes based on a mechanism of chemically induced cell direct reprogramming are disclosed. The small molecule composition can be developed into drug or prodrugs for the treatment of hepatic fibrosis (Cirrhosis), pulmonary fibrosis and fibrosis diseases of other organ or tissue in human. This disclosure also discloses a cell transdifferentiation medium and a reagent prepared by the small molecule composition.

Abstract: Devices, solutions and method capable of quantifying a clinically significant amount of antibodies within a plasma sample obtained from an individual by quantifying binding between antibodies within the sample and microbial proteins are disclosed.

Abstract: The embodiments of the invention provide a color filter substrate and a manufacturing method thereof, and a display device, belonging to the field of display technology. Manufacturing the display device by using the above color filter substrate can simplify the manufacturing process and reduce the cost. The manufacturing method of the color filter substrate comprises: performing a single patterning process to form patterns of a plurality of first black matrixes and second black matrixes which are horizontally and longitudinally intersected, and patterns of a plurality of first touch electrodes positioned on surfaces of the second black matrixes away from a base substrate, wherein the patterns of the first black matrixes and the second black matrixes are intersected to define a plurality of color filter regions arranged in a form of matrix; and forming patterns of color filter layers within the color filter regions.

Abstract: Methods and systems for extracting DNA from a sample are provided. A method includes: lysing red blood cells of the sample using a first solution; dissolving lipids of cellular membranes in the sample using a second solution; and releasing DNA of the sample into a buffer using a third solution.

Abstract: A method for culturing hepatocytes involves maintenance, proliferation, and passaging of the hepatocytes. The method includes culturing the hepatocytes in a culture medium, which includes a hepatocyte basic medium; CHIR99021, which is a GSK-3 beta inhibitor at a concentration of 0.5-10 ?M, SB 431542 or A83-01, which are RGF beta inhibitors, at a concentration of 0.5-10 ?M, N-acetyl-cysteine at a concentration of 0.25-25 mM; and Oncostatin M at a concentration of 1-100 ng/mL There is no exogenous gene introduced into the hepatocytes, and the genetic background of the hepatocytes is not changed.

Abstract: Devices, solutions and method capable of quantifying a clinically significant amount of antibodies within a plasma sample obtained from an individual by quantifying binding between antibodies within the sample and microbial proteins are disclosed.

Abstract: Method and media for diagnosing Crohn's disease are provided. A method of diagnosing Crohn's disease in patients includes: obtaining a sample from an individual; culturing the sample to determine the presence or absence of Mycobacterium avium subspecies hominissuis (MAH) in the sample; and diagnosing the individual with Crohn's disease based on the determining the presence of MAH in the sample.

Abstract: Disclosed is a liquid crystal module detection apparatus for detecting image-sticking, and a detection and evaluation system and method. The apparatus comprises: a sealed thermal-insulating transparent container (1), adapted to contain a liquid crystal module (5) to be tested; a temperature-control module, adapted to adjust the temperature inside the container; a signal generator module (4), adapted to provide a drive signal to the liquid crystal module to be tested. The apparatus employs a sealed, well thermal-insulating, transparent container, and utilizes the heat emitted from the panel and the backlight of the module itself to form a desired temperature environment for detection.

Abstract: Methods and systems for extracting DNA from a sample are provided. A method includes: lysing red blood cells of the sample using a first solution; dissolving lipids of cellular membranes in the sample using a second solution; and releasing DNA of the sample into a buffer using a third solution.

Abstract: A specific culture medium and culture method are for long-term maintenance, proliferation and passaging of human hepatocytes. The culture medium contains a hepatocyte basic medium, a GSK-3 beta inhibitor which is CHIR99021 at a concentration of 0.5-10 ?M, a TGF beta inhibitor which is SB 431542 at a concentration of 0.5-10 ?M and/or a TGF beta inhibitor which is A83-01 at a concentration of 0.5-10 ?M.

Abstract: Method and media for diagnosing Crohn's disease are provided. A method of diagnosing Crohn's disease in patients includes: obtaining a sample from an individual; culturing the sample to determine the presence or absence of Mycobacterium avium subspecies hominissuis (MAH) in the sample; and diagnosing the individual with Crohn's disease based on the determining the presence of MAH in the sample.

Abstract: The embodiments of the invention provide a color filter substrate and a manufacturing method thereof, and a display device, belonging to the field of display technology. Manufacturing the display device by using the above color filter substrate can simplify the manufacturing process and reduce the cost. The manufacturing method of the color filter substrate comprises: performing a single patterning process to form patterns of a plurality of first black matrixes and second black matrixes which are horizontally and longitudinally intersected, and patterns of a plurality of first touch electrodes positioned on surfaces of the second black matrixes away from a base substrate, wherein the patterns of the first black matrixes and the second black matrixes are intersected to define a plurality of color filter regions arranged in a form of matrix; and forming patterns of color filter layers within the color filter regions.

Abstract: An anion conductive material consists of a low-regularity layered double hydroxide having ion conductivity enhanced by delamination of a layer structure of a regular layered double hydroxide.

Abstract: A voltage adjustment method and apparatus of a liquid crystal display (LCD) panel. The method comprises: acquiring initial reference voltage (RV) values of gamma voltage pairs corresponding to respective gray scales, which includes a first and a second gamma voltage; fixing the first gamma voltages, adjusting respectively the second gamma voltages in accordance with flicker values of the brightness of the LCD panel and the initial RV values of the second gamma voltages, and acquiring the adjusted voltage values of the second gamma voltages; and adjusting synchronously, with an equal proportion, the initial RV value of the first gamma voltage and the adjusted voltage value of the second gamma voltage corresponding to each gray scale respectively, so that the brightness corresponding to the gray scale is adjusted to be the same as the brightness corresponding to the same gray scale in the gamma standard voltage curve.

Abstract: According to embodiments of the invention, there are disclosed a liquid crystal display panel and a liquid crystal display device. The liquid crystal display panel comprises: a liquid crystal layer; a conductive structure, surrounding the liquid crystal layer; and a driving circuit, connected to the conductive structure. The driving circuit comprises: a power supply circuit and a switch circuit. The power supply is connected to the conductive structure and provides the conductive structure with a DC voltage. One terminal of the switch circuit is connected to the conductive structure and the other terminal thereof is grounded.